Cargando…

Clinicopathological characteristics of localized prostate cancer in younger men aged ≤ 50 years treated with radical prostatectomy in the PSA era: A systematic review and meta‐analysis

OBJECTIVES: With the rapid increase in younger age prostate cancer (PCa) patients, the impact of younger age on decision‐making for PCa treatment needs to be revaluated in the new era. MATERIALS AND METHODS: A systematic literature search was performed using PubMed, EMBASE, and Web of Science up to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Yu, Lin, Sharron X., Wu, Shulin, Dahl, Douglas M., Blute, Michael L., Zhong, Wei‐De, Zhou, Xing, Wu, Chin‐Lee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520296/ https://www.ncbi.nlm.nih.gov/pubmed/32697048 http://dx.doi.org/10.1002/cam4.3320

Ejemplares similares

Clinicopathological and oncological significance of persistent prostate-specific antigen after radical prostatectomy: A systematic review and meta-analysis
por: Wu, Shulin, et al.
Publicado: (2023)

Black and White men younger than 50 years of age demonstrate similar outcomes after radical prostatectomy
por: Moses, Kelvin A, et al.
Publicado: (2014)

Survival outcomes of younger men (< 55 years) undergoing radical prostatectomy
por: Tan, Lynn, et al.
Publicado: (2018)

Prognostic significance of a novel indicator (PSA(postd3)/PSA(pre)) for PSA recurrence in patients after radical prostatectomy
por: Zhou, Zhien, et al.
Publicado: (2019)

The natural history of a delayed detectable PSA after radical prostatectomy
por: Szymaniak, Julie A., et al.
Publicado: (2023)

Tobacco use and outcome in radical prostatectomy patients
por: Curtis, Alexandra, et al.
Publicado: (2017)

Histopathological results of radical prostatectomy specimen of men younger than 50 years of age at the time of surgery: possible implications for prostate cancer screening programs?
por: Mehring, Gisa, et al.
Publicado: (2023)

PSA mass as a marker of prostate cancer progression after radical prostatectomy
por: Bryniarski, Piotr, et al.
Publicado: (2011)

Heterophilic Antibodies Resulting in False Positive Elevation of PSA After Radical Prostatectomy
por: Asha, Wafa, et al.
Publicado: (2023)

Outcomes of men aged ≤50 years treated with radical prostatectomy: a retrospective analysis
por: Song, Byeongdo, et al.
Publicado: (2019)

Analysis of risk factors for Gleason score upgrading after radical prostatectomy in a Chinese cohort
por: Zhang, Baoling, et al.
Publicado: (2021)

Prostate cancer: a presentation of clinicopathologic prognosticators among Filipino and American men at radical prostatectomy
por: Grageda, Mayen T, et al.
Publicado: (2021)

Open retropubic radical prostatectomy
por: Pereira, Ryan, et al.
Publicado: (2020)

Degree of Preservation of Neurovascular Bundles in Radical Prostatectomy and Recurrence of Prostate Cancer
por: Axén, Elin, et al.
Publicado: (2021)

Randomized Phase 2 Trial of Abiraterone Acetate Plus Prednisone, Degarelix, or the Combination in Men with Biochemically Recurrent Prostate Cancer After Radical Prostatectomy
por: Autio, Karen A., et al.
Publicado: (2021)

Comparison of perioperative outcomes in elderly (age ≧ 75 years) vs. younger men undergoing robot-assisted radical prostatectomy
por: Yamada, Yuta, et al.
Publicado: (2020)

Salvage radiotherapy for patients with PSA relapse after radical prostatectomy: a single institution experience
por: Quero, Laurent, et al.
Publicado: (2008)

Undetectable ultrasensitive PSA after radical prostatectomy for prostate cancer predicts relapse-free survival
por: Doherty, A P, et al.
Publicado: (2000)

Comparison of Pathological and Biochemical Outcomes after Radical Prostatectomy in Korean Patients with Serum PSA Ranges
por: Lee, Hye Won, et al.
Publicado: (2015)

Neoadjuvant PROSTVAC prior to radical prostatectomy enhances T-cell infiltration into the tumor immune microenvironment in men with prostate cancer
por: Abdul Sater, Houssein, et al.
Publicado: (2020)

Characteristics of Patients in SPCG-15—A Randomized Trial Comparing Radical Prostatectomy with Primary Radiotherapy plus Androgen Deprivation Therapy in Men with Locally Advanced Prostate Cancer
por: Gongora, Magdalena, et al.
Publicado: (2022)

Radical Prostatectomy as a First-Line Treatment in Patients with Initial PSA >20 ng/mL
por: Hinev, Alexander I., et al.
Publicado: (2012)

HOXB13 overexpression is an independent predictor of early PSA recurrence in prostate cancer treated by radical prostatectomy
por: Zabalza, Cristina Villares, et al.
Publicado: (2015)

Evaluating the Impact of PSA as a Selection Criteria for Nerve Sparing Radical Prostatectomy in a Screened Cohort
por: Tanguturi, Shyam K., et al.
Publicado: (2014)

Outcomes and toxicity of 313 prostate cancer patients receiving helical tomotherapy after radical prostatectomy
por: Jensen, Lindsay, et al.
Publicado: (2017)

Patient Education for Radical Prostatectomy: Development of a Program Tailored to the Needs of Prostate Cancer Patients
por: Terrier, Jean-Etienne, et al.
Publicado: (2021)

Prediction of Biochemical Recurrence Based on Molecular Detection of Lymph Node Metastasis After Radical Prostatectomy
por: Özdemir, Berna C., et al.
Publicado: (2022)

Effect of Preoperative Multiparametric Magnetic Resonance Imaging on Oncologic and Functional Outcomes Following Radical Prostatectomy
por: Joyce, Daniel D., et al.
Publicado: (2022)

Comparative Survival Outcomes of High-risk Prostate Cancer Treated with Radical Prostatectomy or Definitive Radiotherapy Regimens
por: Aas, Kirsti, et al.
Publicado: (2021)

CHADS2 scores as a predictor of ischemic stroke after radical prostatectomy
por: Yang, Yu‐Wan, et al.
Publicado: (2015)

Down-Regulation of S100A8 is an Independent Predictor of PSA Recurrence in Prostate Cancer Treated by Radical Prostatectomy()
por: Minner, Sarah, et al.
Publicado: (2019)

(68)Ga-PSMA PET/CT for Patients with PSA Relapse after Radical Prostatectomy or External Beam Radiotherapy
por: von Eyben, Finn Edler, et al.
Publicado: (2021)

Outcome of Robotic Radical Prostatectomy in Men Over 74
por: Ubrig, Burkhard, et al.
Publicado: (2018)

Fear of Recurrence in Prostate Cancer Patients: A Cross-sectional Study After Radical Prostatectomy or Active Surveillance
por: Nilsson, Rasmus, et al.
Publicado: (2021)

Reassessment of Prostate Biopsy Specimens for Patients Referred for Robot-assisted Radical Prostatectomy Rarely Influences Surgical Planning
por: Hoekstra, Robert J., et al.
Publicado: (2021)

Incidence of Rectal Injury After Radical Prostatectomy: A Systematic Review and Meta-analysis
por: Romito, Ilaria, et al.
Publicado: (2023)

Retropubic radical prostatectomy: Clinicopathological observations and outcome analysis of 428 consecutive patients
por: Kulkarni, Jagdeesh N., et al.
Publicado: (2011)

Risk of Recurrent Disease 6 Years After Open or Robotic-assisted Radical Prostatectomy in the Prospective Controlled Trial LAPPRO
por: Nyberg, Martin, et al.
Publicado: (2020)

Lack of an Association between Neutrophil-to-Lymphocyte Ratio and PSA Failure of Prostate Cancer Patients Who Underwent Radical Prostatectomy
por: Maeda, Yoko, et al.
Publicado: (2016)

Optimal PSA Threshold for Androgen-Deprivation Therapy in Patients with Prostate Cancer following Radical Prostatectomy and Adjuvant Radiation Therapy
por: Ahn, Hyun Kyu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7ejgin7limf736b9917373cd66